Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aquamin in Subjects at Risk for Colon Cancer
NCT02647671Phase 1Completed
- Start
- Apr 2016
- Primary completion
- Mar 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Lithothamnion calcareum extract in colorectal cancer (CRC) (3 arms). Primary endpoints: Biomarkers of Risk for Colorectal Cancer at 90 days, Colonic-mucosal Associated Microbial Profile at 90 days and 1 more. Started Apr 2016; status: completed.
02
Drugs
Lithothamnion calcareum extract
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02647671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02647671.